losartan has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimura, J | 1 |
| Kato, S | 1 |
| Tamaki, K | 1 |
| Kohno, K | 1 |
| Kaneyuki, U | 1 |
| Maeda, M | 1 |
| Saikusa-Itoh, Y | 1 |
| Hayashida, A | 1 |
| Iida, S | 1 |
| Suefuji, H | 1 |
| Okuda, S | 1 |
1 other study available for losartan and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 2007 |